loader2
Login OPEN ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

All About SMBC and Yes Bank's Merger

16 May 2025|
5 min read |
by ICICI Securities Team

 

In early 2020, Yes Bank faced a dramatic collapse due to years of irresponsible lending, mounting bad loans, and corporate governance issues. The bank's deteriorating financial health eroded investor confidence, leading to a sharp fall in its stock price and withdrawal of deposits. In March 2020, the Reserve Bank of India (RBI) imposed a moratorium, capping withdrawals at Rs 50,000 per account and temporarily taking control to prevent a systemic crisis.

SBI's Rescue Operation

To stabilize the situation, the RBI devised a restructuring plan led by the State Bank of India (SBI). SBI infused Rs 7,250 crore into Yes Bank, becoming its largest shareholder. The bailout was supported by other banks (Axis Bank, Kotak Mahindra Bank, ICICI Bank, and HDFC Bank) and financial institutions (LIC), ensuring that Yes Bank could meet its obligations and resume normal operations. This coordinated intervention restored depositor confidence, helped avoid a broader financial contagion, and offered a model for rescuing distressed private sector banks.

The Good News

Yes Bank took a couple of years to clean its books and has started giving good results in the last few quarters. However, for investors, there has not been much progress in terms of share price. However, the recent news around Sumitomo Mitsui Banking Corporation (SMBC) acquiring a controlling stake in the bank is a big positive for the bank and its investors.

Investors should note that the M&A talk first started in 2024 but could not go through. Now, there have been some changes in the deal terms, and the deal may go through. As per reports, SBI (currently holding 23.97% stake) is likely to sell around 20% of its total holding to SMBC. It is also expected that the Japanese giant will infuse fresh capital of 6 to 7%. It may also make an open offer to take its stake in Yes Bank to 51% (majority shareholder).

As of now,  it remains unclear whether other stakeholders such as HDFC Bank, ICICI Bank, Kotak Mahindra Bank, Axis Bank, LIC, Carlyle, and Advent International will exit or remain invested.

The Challenges

As mentioned above, the SMBC wants 51% controlling and also 51% voting rights in Yes Bank. However, Indian banking laws cap voting rights for promoters in private sector banks at 26%. Despite this, SMBC appears willing to proceed. Previous discussions with SMBC and Mitsubishi UFJ Financial Group (MUFG) fell through last year over the same concern, but SMBC has now become interested despite the regulatory cap.

To maintain operational and managerial influence, SMBC may seek representation on key board committees such as the Nomination and Remuneration Committee (NRC), which plays a central role in leadership appointments, including that of the CEO. Although SMBC’s full consolidation of Yes Bank at the parent level may require jurisdictional approvals in Japan, the deal could be finalized within this fiscal year, subject to SMBC’s agreement to Indian regulations and regulatory approvals.

Before you go

Prashant Kumar (current CEO) is set to complete his term in October. If the deal goes through, SMBC will recommend candidates for the role to the central bank. India has already been carved out as a separate operating region by SMBC in preparation for the acquisition. It will also be the biggest private bank M&A in India.

Disclaimer: ICICI Securities Ltd.( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Centre, H. T. Parekh Marg, Churchgate, Mumbai - 400020, India, Tel No : 022 - 2288 2460, 022 - 2288 2470.  The contents herein above shall not be considered as an invitation or persuasion to trade or invest.  Investments in securities market are subject to market risks, read all the related documents carefully before investing. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The contents are solely for informational and educational purpose.

Share
instagram facebook twitter linkedin mail whatsApp
Did you enjoy this article?

Recent Articles

View all

Repo Rate Hike Explained: Impact on Loans, Deposits, Bonds and Stock Market

13 Oct 2026

The Reserve Bank of India (RBI) held its 63rd Monetary Policy Committee (MPC) meeting from October 5 to 7, 2026. It raised the policy repo rate by 25 basis points. The stance was also changed from ‘neutral’ to ‘calibrated tightening’. India’s economy continued to show strong momentum, with real Gross Domestic Product (GDP) growing by 7.8% in Q1 FY2026-27. While inflation rose to 4.8% in August, the overall economic outlook remained positive. However, rise in crude oil prices amid renewed tensions in West Asia added to global uncertainties. This made it imperative for the RBI to strike a balance between the economic growth and price stability....

Jio Platforms IPO Review: Reasons for Launching an IPO & Industry Details

09 Oct 2026

Jio Platforms is the company behind Reliance Jio's mobile network, home broadband and a growing line-up of AI-powered products. The company filed its Draft Red Herring Prospectus (DRHP) with SEBI on June 19, 2026, and Red Herring Prospectus (RHP) on October 14, 2026. The Jio Platforms IPO opens on October 21, 2026 and closes on October 23, 2026. The RHP gives details about how the Jio Platforms IPO is structured, who currently owns the company, and where the raised money will be used. This article analyses RHP and says about how the issue is structured, how it is divided among investors, who is managing it, who owns the company today, the numbers behind the business and the market it operates in. It is for information only and not an investment advice....

Natco Pharma Ltd. Rights Issue: Price, Record Date, Entitlement Ratio And Key Details

09 Oct 2026

The Natco Pharma Ltd. rights issue is proposed at ₹750 per share, with eligible shareholders entitled to two rights equity shares for every 21 fully paid-up equity shares held on the record date. The issue is scheduled to open on October 12, 2026, and close on October 22, 2026. The pharmaceutical company plans to raise up to ₹1,279.35 crore through the issue, subject to full subscription and the finalisation of the basis of allotment....

Download
ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere

Download
ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere